Cancer Care Ontario | Cancer Care Ontario

197 Results

Guidelines and Advice

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Status: Current
ID: MOTAC-7

Updated

Jan 2025

Guidelines and Advice

Guidance on the Substitution of Systemic Therapy Agents

Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Guidelines and Advice

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Status: Current
ID: GL-C50-30

Feb 2017

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Apr 2017

Guidelines and Advice

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Status: Archived
ID: 7-4
Version: 2

Dec 2017

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

Cancer facts

Reported Tobacco Screening Increases among New Cancer Patients

Jan 2017

Cancer facts

Cancer rates increasing among children in Ontario

Nov 2017

Guidelines and Advice

Models of Care for Cancer Survivorship

Status: Current
ID: 26-1
Version: 2

Mar 2017

Cancer facts

Ontario Cancer Profiles Lets You Explore Cancer Statistics

Aug 2017

Statistical Reports

Ontario Cancer Statistics 2024

Ontario Cancer Statistics 2024 is the fifth in a series of reports that provide comprehensive information on the burden of cancer in Ontario....

New

Feb 2025

Guidelines and Advice

Follow-up After Primary Therapy for Endometrial Cancer

Status: Current
ID: 4-9
Version: 2

Jun 2017

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Guidance on the Substitution of Systemic Therapy Agents

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Reported Tobacco Screening Increases among New Cancer Patients

Cancer rates increasing among children in Ontario

Models of Care for Cancer Survivorship

Ontario Cancer Profiles Lets You Explore Cancer Statistics

Ontario Cancer Statistics 2024

Follow-up After Primary Therapy for Endometrial Cancer

Pages